+1 877 705 1914• 24 / 7
HIPAA Compliant
ISO 27001 Certified

Actively Recruiting

Phase 2
Age: 18Years - 70Years
All Genders
ID06657690

Phase 2 Study of Irinotecan Liposome and S-1 Treatment for Recurrent or Metastatic Nasopharyngeal Carcinoma Resistant to PD-1L1 Inhibitors

Led by Sun Yat-sen University · Updated on 2025-01-10

56

Participants Needed

1

Research Sites

52 weeks

Total Duration

AI-Summary

What This Trial Is About

Researchers are conducting a prospective, single-arm Phase 2 study to assess the effectiveness and safety of combining Irinotecan Liposome injection with S-1 in patients with recurrent or metastatic nasopharyngeal carcinoma NPC who have not responded to at least first-line anti-PD-1L1 therapy. This study focuses on patients whose cancer cannot be treated with local curative methods and aims to provide new options for those who have progressed despite previous immunotherapy or chemotherapy. Participants will receive Irinotecan Liposome injection at 50 mgm2 on days 1 and 15 via intravenous infusion every 4 weeks, combined with oral S-1 taken twice daily from days 1 to 14 in 4-week cycles. The dosing of S-1 is adjusted based on body surface area. Treatment continues for up to 6 cycles or until disease progression, unacceptable side effects, withdrawal, new cancer treatment, loss of follow-up, or death. Regular visits and imaging scans will monitor treatment effects and safety. During the study, participants will undergo evaluations including imaging tests to measure tumor response according to RECIST 1.1 criteria. Researchers will monitor objective response rate as the primary outcome and also track progression-free survival, overall survival, and adverse events over about one year. Participants will be followed closely throughout treatment and assessed regularly to gather comprehensive data on treatment impact and safety.

CONDITIONS

Brief Title

Irinotecan Liposome Combined with S-1 in PD-1/L1 Inhibitor Refractory Recurrent or Metastatic NPC

Research Team

M

Mingyuan Chen, MD, PhD

R

Rui You, MD, PhD

Not the Right Trial for You?

Explore thousands of other clinical trials that might be a better match.
Sign up to get personalized trial recommendations delivered to your inbox.

Already have an account? Log in here